Literature DB >> 19561099

Pulmonary inflammation triggered by ricin toxin requires macrophages and IL-1 signaling.

Meghan L Lindauer1, John Wong, Yoichiro Iwakura, Bruce E Magun.   

Abstract

Ricin is a potent ribotoxin considered to be a potentially dangerous bioterrorist agent due to its wide availability and the possibility of aerosol delivery to human populations. Studies in rodents and nonhuman primates have demonstrated that ricin delivered to the pulmonary system leads to acute lung injury and symptoms resembling acute respiratory distress syndrome. Increasing evidence suggests that the inflammatory effects triggered by ricin are responsible for its lethality. We demonstrated previously that ricin administered to the lungs of mice causes death of pulmonary macrophages and the release of proinflammatory cytokines, suggesting macrophages may be a primary target of ricin. Here we examined the requirement for macrophages in the development of ricin-mediated pulmonary inflammation by employing transgenic (MAFIA) mice that express an inducible gene driven by the c-fms promoter for Fas-mediated apoptosis of macrophages upon injection of a synthetic dimerizer, AP20187. Administration of aerosolized ricin to macrophage-depleted mice led to reduced inflammatory responses, including recruitment of neutrophils, expression of proinflammatory transcripts, and microvascular permeability. When compared with control mice treated with ricin, macrophage-depleted mice treated with ricin displayed a reduction in pulmonary IL-1beta. Employing mice deficient in IL-1, we found that ricin-induced inflammatory responses were suppressed, including neutrophilia. Neutrophilia could be restored by co-administering ricin and exogenous IL-1beta to IL-1alpha/beta(-/-) mice. Furthermore, IL1Ra/anakinra cotreatment inhibited ricin-mediated inflammatory responses, including recruitment of neutrophils, expression of proinflammatory genes, and histopathology. These data suggest a central role for macrophages and IL-1 signaling in the inflammatory process triggered by ricin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561099      PMCID: PMC4467824          DOI: 10.4049/jimmunol.0901119

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

Review 1.  Microbiological, biological, and chemical weapons of warfare and terrorism.

Authors:  Ronald A Greenfield; Brent R Brown; James B Hutchins; John J Iandolo; Rhett Jackson; Leonard N Slater; Michael S Bronze
Journal:  Am J Med Sci       Date:  2002-06       Impact factor: 2.378

2.  Role of apoptotic signaling pathways in regulation of inflammatory responses to ricin in primary murine macrophages.

Authors:  Veselina Korcheva; John Wong; Meghan Lindauer; David B Jacoby; Mihail S Iordanov; Bruce Magun
Journal:  Mol Immunol       Date:  2007-01-25       Impact factor: 4.407

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

5.  Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.

Authors:  Veselina Korcheva; John Wong; Christopher Corless; Mihail Iordanov; Bruce Magun
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

6.  IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

Authors:  Pamela Gasse; Caroline Mary; Isabelle Guenon; Nicolas Noulin; Sabine Charron; Silvia Schnyder-Candrian; Bruno Schnyder; Shizuo Akira; Valérie F J Quesniaux; Vincent Lagente; Bernhard Ryffel; Isabelle Couillin
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.

Authors:  Richard A Johnston; Joseph P Mizgerd; Lesley Flynt; Lee J Quinton; Erin S Williams; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

8.  ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression.

Authors:  Dakshina M Jandhyala; Amrita Ahluwalia; Tom Obrig; Cheleste M Thorpe
Journal:  Cell Microbiol       Date:  2008-03-10       Impact factor: 3.715

9.  Clinical risks for development of the acute respiratory distress syndrome.

Authors:  L D Hudson; J A Milberg; D Anardi; R J Maunder
Journal:  Am J Respir Crit Care Med       Date:  1995-02       Impact factor: 21.405

10.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.

Authors:  J Han; J D Lee; L Bibbs; R J Ulevitch
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

View more
  39 in total

1.  Toxicity of ricin A chain is reduced in mammalian cells by inhibiting its interaction with the ribosome.

Authors:  Amanda E Jetzt; Xiao-Ping Li; Nilgun E Tumer; Wendie S Cohick
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-15       Impact factor: 4.219

2.  Chimeric plantibody passively protects mice against aerosolized ricin challenge.

Authors:  Erin K Sully; Kevin J Whaley; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do H Kim; Michael H Pauly; Jesus Velasco; Ernie Hiatt; Josh Morton; Kelsi Swope; Chad J Roy; Larry Zeitlin; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

Review 3.  Immunity to ricin: fundamental insights into toxin-antibody interactions.

Authors:  Joanne M O'Hara; Anastasiya Yermakova; Nicholas J Mantis
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury.

Authors:  Heather D Jones; Timothy R Crother; Romer A Gonzalez-Villalobos; Madhulika Jupelli; Shuang Chen; Jargalsaikhan Dagvadorj; Moshe Arditi; Kenichi Shimada
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

5.  Potent Antiedematous and Protective Effects of Ciprofloxacin in Pulmonary Ricinosis.

Authors:  Yoav Gal; Anita Sapoznikov; Reut Falach; Sharon Ehrlich; Moshe Aftalion; Tamar Sabo; Chanoch Kronman
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

6.  Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).

Authors:  Anastasiya Yermakova; Nicholas J Mantis
Journal:  Vaccine       Date:  2011-08-26       Impact factor: 3.641

7.  Isoflurane attenuates lipopolysaccharide-induced acute lung injury by inhibiting ROS-mediated NLRP3 inflammasome activation.

Authors:  Ning Yin; Zhendan Peng; Bin Li; Jiangyan Xia; Zhen Wang; Jing Yuan; Lei Fang; Xinjiang Lu
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

8.  The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.

Authors:  Leonid P Shutov; Charles A Warwick; Xiaoyu Shi; Aswini Gnanasekaran; Andrew J Shepherd; Durga P Mohapatra; Trent M Woodruff; J David Clark; Yuriy M Usachev
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

9.  Pathology of lethal and sublethal doses of aerosolized ricin in rhesus macaques.

Authors:  Manoj Bhaskaran; Peter J Didier; Satheesh K Sivasubramani; Lara A Doyle; Jane Holley; Chad J Roy
Journal:  Toxicol Pathol       Date:  2013-06-11       Impact factor: 1.902

10.  An intranasally administered monoclonal antibody cocktail abrogates ricin toxin-induced pulmonary tissue damage and inflammation.

Authors:  Yinghui Rong; Fernando J Torres-Velez; Dylan Ehrbar; Jennifer Doering; Renjie Song; Nicholas J Mantis
Journal:  Hum Vaccin Immunother       Date:  2019-10-29       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.